PolyPeptide Aktie
28,90CHF | 0,30CHF | 1,05% |
WKN DE: A3CNHV / ISIN: CH1110760852
Aktionärsstruktur
Inhaber | in % |
---|---|
Frederik Paulsen | 56,10 |
Freefloat | 40,24 |
Premier Miton Investment Fds. 3 - European Opportunities Fund | 5,74 |
Premier Fund Managers Ltd. | 5,17 |
Rudolf Maag | 3,32 |
Newtyn Management LLC | 3,00 |
PRIMECAP Management Co. | 2,99 |
T. Rowe Price International Ltd. | 2,99 |
PRIMECAP Odyssey Aggressive Growth Fund | 2,75 |
BlackRock Global Funds - Swiss Small & Mid Cap Opp. Fd. | 1,07 |
HBM Healthcare Investments AG | 0,91 |
Berenberg European Small Cap | 0,87 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 877 | 973 | 1 101 | 1 219 | 1 273 |
Umsatz pro Mitarbeiter in Mio. EUR | 0,26 | 0,25 | 0,28 | 0,23 | 0,24 |
Bilanz (in Mio. CHF) - Aktiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 155 | 195 | 344 | 248 | 304 |
Summe Anlagevermögen | 177 | 212 | 273 | 320 | 337 |
Summe Aktiva | 332 | 407 | 617 | 569 | 641 |
Bilanz (in Mio. CHF) - Passiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Summe Fremdkapital | 169 | 214 | 180 | 152 | 286 |
Summe Eigenkapital | 162 | 192 | 436 | 416 | 354 |
Summe Passiva | 332 | 407 | 617 | 569 | 641 |
Adresse
Neuhofstrasse 24, 6340 Baar | |
Telefon | +41 (43) 502-05-80 |
Internet | http://www.polypeptide.com |
Management
Beat In-Albon
Independent Non-Executive Director |
Christina del Vecchio
Secretary & General Counsel |
Erik Schropp
Non-Executive Director |
Jane Anne Salik
Non-Executive Director |
Jens Fricke
Director-Global Operations |
Jon Holbech Rasmussen
Director-Global Development, IP & Regulatory |
Juan-José Gonzalez
Chief Executive Officer |
Marc Augustin
Chief Financial Officer |
Michael Stäheli
Head-Investor Relations & Corporate Communications |
Monika Casanova
Chief Human Resources Officer |
Neil James Thompson
Director-Global Sales & Marketing |
Olivier Ludemann-Hombourger
Director-Global Innovation & Technology |
Patrick Aebischer
Vice Chairman |
Peter Wilden
Chairman |
Philippe A. Weber
Independent Non-Executive Director |